Patents by Inventor Shourong Wu

Shourong Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polyion complex comprising PHD2 expression inhibiting substance
    Patent number: 8791086
    Abstract: The present invention aims to provide a gene delivery system with higher safety and higher sustainability, which is effective for the treatment of ischemic diseases and the like, and the like. The present invention provides a pharmaceutical composition containing, as an active ingredient, a polyanionic substance that suppresses expression of PHD2, and containing a polyion complex of the polyanionic substance and a polycation chargeable polymer.
    Type: Grant
    Filed: July 22, 2010
    Date of Patent: July 29, 2014
    Assignee: The University of Tokyo
    Inventors: Kazunori Kataoka, Shourong Wu, Nobuhiro Nishiyama, Keiji Itaka, Hiroyuki Koyama, Takuya Hashimoto, Yuichi Tei
  • Cationic poly (amino acids) and uses thereof
    Patent number: 8546487
    Abstract: The present invention provides an efficient delivery system for a nucleic acid, more specifically, a cationic poly(amino acid) that has a side chain having a plurality of different amine functional groups in a moiety including a cationic group and that has a hydrophobic group introduced into part of the side chain, and a polyion complex (PIC) of the poly(amino acid) and an oligo- or polynucleotide.
    Type: Grant
    Filed: February 15, 2010
    Date of Patent: October 1, 2013
    Assignee: The University of Tokyo
    Inventors: Kazunori Kataoka, Shourong Wu, Takehiko Ishii, HyunJin Kim, Kanjiro Miyata, Nobuhiro Nishiyama
  • POLYION COMPLEX COMPRISING PHD2 EXPRESSION INHIBITING SUBSTANCE
    Publication number: 20120177594
    Abstract: The present invention aims to provide a gene delivery system with higher safety and higher sustainability, which is effective for the treatment of ischemic diseases and the like, and the like. The present invention provides a pharmaceutical composition containing, as an active ingredient, a polyanionic substance that suppresses expression of PHD2, and containing a polyion complex of the polyanionic substance and a polycation chargeable polymer.
    Type: Application
    Filed: July 22, 2010
    Publication date: July 12, 2012
    Inventors: Kazunori Kataoka, Shourong Wu, Nobuhiro Nishiyama, Keiji Itaka, Hiroyuki Koyama, Takuya Hashimoto, Yuichi Tei
  • CATIONIC POLY (AMINO ACIDS) AND USES THEREOF
    Publication number: 20120053295
    Abstract: The present invention provides an efficient delivery system for a nucleic acid, more specifically, a cationic poly(amino acid) that has a side chain having a plurality of different amine functional groups in a moiety including a cationic group and that has a hydrophobic group introduced into part of the side chain, and a polyion complex (PIC) of the poly(amino acid) and an oligo- or polynucleotide.
    Type: Application
    Filed: February 15, 2010
    Publication date: March 1, 2012
    Applicant: The University of Tokyo
    Inventors: Kazunori Kataoka, Shourong Wu, Takehiko Ishii, HyunJin Kim, Kanjiro Miyata, Nobuhiro Nishiyama